- Zacks•6 hours ago
Third quarter earnings season is in full flow with several companies like Lilly (LLY), Merck, Bristol-Myers, Novartis and others reporting results this week.
- Reuters•19 hours ago
The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines * Special visa schemes for regions rejected http://on.ft.com/2eVztAW ...
- Financial Times•yesterday
Drugmaker AstraZeneca's US-listed shares fell 4 per cent on Thursday after it announced that US regulators had dealt a setback to its prospective cancer drug durvalumab by placing a temporary halt on enrolling ...
AstraZeneca PLC (AZN.L)
LSE - LSE Delayed Price. Currency in GBp
|Bid||4,500.00 x 6100|
|Ask||5,100.00 x 13000|
|Day's Range||4,533.50 - 4,850.29|
|52wk Range||3,680.00 - 5,505.00|
|1y Target Est||N/A|
|P/E Ratio (ttm)||26.38|
|Avg Vol (3m)||2,625,316|
|Dividend & Yield||N/A (N/A)|